Clinical Trial Update: Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of voxilaprevir with sofosbuvir/velpatasvir fixed-dose combination for adults with chronic genotype 1 hepatitis C in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• voxilaprevir + sofosbuvir/velpatasvir fixed-dose combination

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-12-08